StockClub

ESPR

ESPREsperion Therapeutics, Inc.$ --
Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc.

ESPR

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

analyticsEarnings Summary

FY2026 Q1Updated: 03/31/2026

Revenue

attach_money
80M USD
-

Operating Income

trending_up
-7M USD
-

Net Income

verified
-25M USD
-

EPS

paid
-0.1$
-

Revenue

$80.1M

MISS
$94.9M
$80.1M
Q1
$94.9M
$80.1M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2026 Q1 YoY
- $-

Net Income

$-25.2M

MISS
$-6.6M
$-25.2M
Q1
$-6.6M
$-25.2M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2026 Q1 YoY
- $-

Surprise History

ActualEstimate
FY2025BEAT
$403.1M

Future Forecast